Pesquisas alternativas:
novel ether » novel tethered (Expandir a Pesquisa), novelli ethel (Expandir a Pesquisa), novel fathers (Expandir a Pesquisa)
novel ther » novel theory (Expandir a Pesquisa), novel thermo (Expandir a Pesquisa), novel anther (Expandir a Pesquisa)
devel ther » level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
novel thr » novel thrb (Expandir a Pesquisa), novel th2 (Expandir a Pesquisa), novel three (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
novel ether » novel tethered (Expandir a Pesquisa), novelli ethel (Expandir a Pesquisa), novel fathers (Expandir a Pesquisa)
novel ther » novel theory (Expandir a Pesquisa), novel thermo (Expandir a Pesquisa), novel anther (Expandir a Pesquisa)
devel ther » level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
novel thr » novel thrb (Expandir a Pesquisa), novel th2 (Expandir a Pesquisa), novel three (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
121
Por Ochiya, Takahiro, Takenaga, Keizo, Asagiri, Masataka, Nakano, Kazumi, Satoh, Hitoshi, Watanabe, Toshiki, Imajoh-Ohmi, Shinobu, Endo, Hideya
Publicado no Mol Ther Methods Clin Dev (2015)
“... peptide capable of blocking S100A4-effector protein interaction could be a novel antiangiogenic agent...”Publicado no Mol Ther Methods Clin Dev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
122
“.... maxima be considered as potential novel drug hits in the treatment of schistosomiasis....”
Obter o texto integral
Obter o texto integral
Artigo
123
“... step towards tumor invasion and metastasis, and intimately involved in de novo and acquired drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
124
“... using the United States Food and Drug Administration (FDA)-approved, AMPK-activating, antidiabetic drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
125
Por Mitsui, Kaoru, Ide, Kanako, Takayama, Akiko, Wada, Tadahisa, Irie, Rie, Kosai, Ken-ichiro
Publicado no Mol Ther Methods Clin Dev (2015)
“... developed as anticancer drugs, may also be useful as novel antitumorigenic agents in hPSC-based therapy...”Publicado no Mol Ther Methods Clin Dev (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
126
Por Liu, Si-jun, Yang, Cong, Zhang, Yue, Su, Ru-yu, Chen, Jun-li, Jiao, Meng-meng, Chen, Hui-fang, Zheng, Na, Luo, Si, Chen, Yun-bo, Quan, Shi-jian, Wang, Qi
Publicado no Drug Des Devel Ther (2016)
“... AND METHODS: APPswe/PS1dE9 double transgenic male mice were randomly assigned to a model group, β-asarone...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
127
Por Zhou, Yunfei, Bollu, Lakshmi Reddy, Tozzi, Federico, Ye, Xiangcang, Bhattacharya, Rajat, Gao, Guang, Dupre, Elizabeth, Xia, Ling, Lu, Jia, Fan, Fan, Bellister, Seth, Ellis, Lee M, Weihua, Zhang
Publicado no Mol Cancer Ther (2013)
“... patients develop drug resistance. Understanding the mechanisms that lead to resistance to individual...”Publicado no Mol Cancer Ther (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
128
Por Zhu, Juanjuan, Ren, Tingting, Zhou, Mingyu, Cheng, Mingliang
Publicado no Drug Des Devel Ther (2016)
“... group (CG). AFLD mice models were established with Lieber–DeCarli ethanol diet and evenly assigned...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
129
Por Laure Delavallée, Navrita Mathiah, Lauriane Cabon, Aurélien Mazeraud, Marie-Noelle Brunelle-Navas, Leticia K. Lerner, Mariana Tannoury, Alexandre Prola, Raquel Moreno-Loshuertos, Mathieu Baritaud, Laura Vela, Kevin Garbin, Delphine Garnier, Christophe Lemaire, Francina Langa-Vives, Martine Cohen-Salmon, Patricio Fernández-Silva, Fabrice Chrétien, Isabelle Migeotte, Santos A. Susin
Publicado em 2020-10-01
“... and the subsequent oxidative phosphorylation (OXPHOS) dysfunction. Methods: We developed a novel AIF-deficient mouse...”Publicado em 2020-10-01
Obter o texto integral
Artigo
130
“..., response rates are low, due in part to the drug-resistant nature of this disease; therefore, new avenues...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
131
Por Scott, David R., Munson, Keith B., Marcus, Elizabeth A., Lambrecht, Nils W. G., Sachs, George
Publicado no Aliment Pharmacol Ther (2015)
“... recently, the only drugs that effectively inhibited this ATPase were the proton pump inhibitors (PPIs...”Publicado no Aliment Pharmacol Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
132
“...Lenalidomide, a novel immunomodulatory drug (IMiD), is a promising therapeutic strategy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
133
Por Chen, Wenxue, Bardhan, Rizia, Bartels, Marc, Perez-Torres, Carlos, Pautler, Robia G., Halas, Naomi J., Joshi, Amit
Publicado em 2010
“... cancer, it can be employed as a docking site for directed nanotherapies in cases with de novo or acquired...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
134
Por Khoury, Gabriela, Ewart, Gary, Luscombe, Carolyn, Miller, Michelle, Wilkinson, John
Publicado no AIDS Res Ther (2016)
“... de novo intracellular virus produced in ‘virus-containing compartments’ of MDM. In primary infections...”Publicado no AIDS Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
135
Por Nawa, Nobutoshi, Ishida, Hidekazu, Katsuragi, Shinichi, Baden, Hiroki, Takahashi, Kunihiko, Higeno, Ryota, Torigoe, Fumiko, Mihara, Seiko, Narita, Jun, Miura, Kohji, Nakamura, Kazufumi, Kogaki, Shigetoyo, Ozono, Keiichi
Publicado no Mol Ther Methods Clin Dev (2016)
“... ligand stimulation than existing drugs. The aim of this study was to investigate the therapeutic effects...”Publicado no Mol Ther Methods Clin Dev (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
136
Por Yanamandra, Niranjan, Buzzeo, Robert W., Gabriel, Mark, Hazlehurst, Lori A., Mari, Yelenis, Beaupre, Darrin M., Cuevas, Javier
Publicado em 2011
“..., promotes synergistic death and overcomes de novo drug resistance in acute myeloid leukemia cell lines...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
137
Por Shi, Huan, Cao, Ningning, Pu, Yiping, Xie, Lisong, Zheng, Lingyan, Yu, Chuangqi
Publicado no Arthritis Res Ther (2016)
“... revealed that 28 of the differentially expressed (DE) mRNAs were associated with eight DE lncRNAs involved...”Publicado no Arthritis Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
138
“... is useful for the excretion of excess nitrogen in the form of glycine. Drugs which can substitute...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
139
“...PURPOSE: Dronedarone is a novel multichannel blocker with antiadrenergic and vasodilatory...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
140
Por Ramin Tehranchi, MD, PhD, MBA, Jonas Pettersson, MD, PhD, Anita E. Melgaard, MSc, Friedeborg Seitz, MD, Anders Valeur, PhD, Stine Just Maarbjerg, PhD
Publicado em 2022-01-01
“... risk of drug-induced QTc prolongation and potential for fatal cardiac arrhythmias such as torsades de...”Publicado em 2022-01-01
Obter o texto integral
Artigo